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1 Introduction
Polymerase chain reaction (PCR)-based tests are commonly used to detect various infections
(e.g. Chlamydia trachomatis, Mycoplasma genitalium, Human papilloma virus). Typically,
such tests consist of a PCR amplification step to increase (by several orders of magnitude)
the number of copies of a target DNA sequence in the sample, followed by detection of these
“PCR products” by hybridization to a internal sequence after immobilization of the products
on microwell plates or nytran filters. The result of the detection step is simply positive or
negative for the target DNA sequence. Although such tests are universally acknowledged
to be highly “sensitive” for the target DNA sequence - claims are often made that the
test can detect a single molecule of the target DNA in a sample - no universally accepted
definition of, or method for estimating, sensitivity exists. Some authors define sensitivity as
the probability of a positive test when the target DNA sequence is present and specificity as
the probability of a negative test when the target is absent (Rodrigo et al., 1997). However,
this ignores the possibility that the probability of a positive test may vary depending on
whether 1 copy or 20 copies of the target are present. Others characterize sensitivity in
terms of the minimum number of molecules of target DNA that are detectable (e.g. Sykes
et al, 1992) but this implies that the probability of detection is 1.0 at or above the detection
limit and zero below it, which may not be true. Thus, it is unclear how these values should
be interpreted.
In addition to the lack of a standard definition of sensitivity, there has been little work on
estimating the sensitivity of a given test. In some cases, the test is implicitly assumed to be
perfect - sensitivity and specificity equal to 1.0 (e.g. Shapiro, 1999). Rodrigo et al. (1997)
explicitly incorporated a user-specified specificity and sensitivity into an analysis of HIV
viral load levels. As noted above, however, they assumed, that the sensitivity was constant
for all concentrations greater than 0. In addition, Rodrigo et al. did not indicate how the
sensitivity could be estimated. Sykes et al. (1992) used an endpoint dilution experiment (see
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below) to estimate an index of sensitivity they called the “mean number of copies detected”.
The authors treat this quantity like a detection limit although no explicit interpretation is
given.
We propose that test sensitivity should be defined as the probability of a positive test
and expressed as a function of the number of target DNA molecules in the sample (or
specificity when the number of target molecules is zero). An endpoint dilution experiment
may then be used to estimate this “sensitivity curve”. Specifically, a sample containing a
known concentration of the target DNA is serially diluted to yield solutions with varying
(but known) concentrations of the target. Denote the concentration of target DNA molecules
in the i’th dilution as λi, i = 1...M , (λi = 0 for the negative controls). At each of the M
dilutions, ki aliquots are sampled, amplified by PCR and tested for the presence of the target
DNA. The observed data consist of the counts of positive (xi) and negative tests (ki−xi) at
each dilution. This design is similar to a limiting dilution assay (LDA), which is often used
to estimate an unknown concentration or proportion of targets in the original sample.
A simple estimate of specificity from such an experiment is the proportion of negative
tests seen in the negative control samples. False positive tests in the negative controls may
result if the PCR primers bind to and amplify non-target DNA sequences. Estimation of
sensitivity as a function of the number of copies of the target DNA in the sample is more
problematic, however. An important limitation of the endpoint dilution procedure described
above is that, although the expected or average concentration of pathogen at the i’th dilution
level is known, the researcher typically cannot control the exact number of DNA copies in
each aliquot. Thus, false negative tests may occur for one of two reasons: 1) although the
aliquot used for testing was taken from a solution with λi > 0, the aliquot contained no copies
of the target DNA, or 2) although the aliquot used for testing contained one or more copies of
the target DNA, the PCR procedure failed to amplify the DNA. It is the second reason that
characterizes the true sensitivity of the test procedure. The first reason is simply an artifact
of the experimental setup and is not related to the actual performance of the test. For this
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reason we distinguish between the “observed” test sensitivity (the probability of detecting
the pathogen in a sample taken from a solution with a known mean DNA concentration) and
the “true” test sensitivity (the probability of detecting the pathogen in a sample containing
a known number of the target DNA molecules).
Observed sensitivity may be estimated in a straightforward manner from the observed
data using standard statistical tools such as logit or probit regression. In contrast, it is not
possible to directly measure the true sensitivity since the exact number of DNA molecules
in each sample is unknown. Nonetheless, it is possible, under reasonable assumptions, to
estimate the true sensitivity and this gives a better indication of the performance of the test.
For instance, suppose a 63% detection rate is observed when the mean concentration is 1.0
molecule of DNA per aliquot (i.e. observed sensitivity = 0.63). It turns out (details below)
that this is the expected observed sensitivity when the true sensitivity is 1.0. Thus, it would
be a waste of time to try to improve the test further, a conclusion that is not immediately
obvious otherwise.
In section 2 we introduce a model for relating true sensitivity to the observed sensitivity
and show how the single hit Poisson model described by Taswell (1981) may be used to
estimate the true sensitivity under a particular set of assumptions about the form of the
sensitivity curve. We then investigate ways of relaxing these assumptions. In section 3, we
apply these methods to an endpoint dilution experiment designed to measure the sensitivity
of a test for M. genitalium. We summarize our findings and discuss extensions in section 4.
2 Models
We define the true sensitivity and specificity in terms of a function f(n) where f(n) =
Pr(positive test | exactly n DNA molecules in the sample). Thus, specificity is equal to
1− f(0) and sensitivity is defined by the function f(n) for n > 1.
As noted above, f cannot be estimated from the data without further assumptions. The
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key assumption is that, conditional on the mean concentration, λ, the actual number of DNA
molecules, n, in an aliquot of volume v follows a Poisson distribution with mean µ = λv.
That is,
Pr(n | µ) = µ
ne−µ
n!
. (1)
This assumption has been used extensively in the analysis of data from limiting dilution
experiments (Sykes et al., 1992; Sharrock et al., 1990; Shapiro, 1999) and is reasonable if
the dilution from which the aliquot is drawn is well mixed and there is no clumping of DNA
molecules.
The observed sensitivity and specificity of the PCR procedure can then be characterized
in terms of f and µ. Let h(µ) denote the observed sensitivity when the mean number of
DNA molecules in the sample is known to be µ (1− h(µ) is the specificity when µ = 0):
h(µ) =
∞3
n=0
f(n)µne−µ
n!
(2)
Note that even with perfect true sensitivity and specificity (f(0) = 0 and f(n) = 1 for
n > 1), the observed sensitivity, h, is only 0.63 when λ = 1.
The functional form of f is unknown and in the following we investigate parametric,
semiparametric (spline-based) and nonparametric models for f . Each has advantages and
disadvantages. In each case, however, we restrict our attention to functions that are monoton-
ically increasing in n since it seems reasonable to assume that the sensitivity must increase
as the number of DNA molecules in the sample increases.
2.1 Parametric model for f
A number of parametric models for f are possible. We investigate the following,
f(n) = 1− φ(1− θ)n. (3)
This model may be interpreted mechanistically as follows: suppose that each of the n DNA
molecules in the sample has an independent probability of 1− θ of “escaping” amplification
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by PCR. If one or more of the n molecules are amplified then the sample will test positive
while if none of the nmolecules are amplified then the solution will test negative. In addition,
there is a 1− φ probability that the sample will test positive even if no DNA molecules are
present (so φ is the specificity). For this model, h(µ) in (2) reduces to the closed form
h(µ) = 1− φe−θµ (4)
For φ = 1 this model is identical to the single-hit Poisson model used by Taswell (1981) and
others to analyze limiting dilution assay (LDA) data. In LDA experiments, however, θ is
the fraction of a particular cell type in a mixture of cell types. Here, θ characterizes the
test sensitivity. If φ = 1, θ corresponds to the test sensitivity when a single DNA molecule
is present and is equal to the inverse of the “mean number of copies detected” defined by
Sykes et al. (1992). Use of the single hit Poisson model for the analysis of LDA data has
been extensively studied (e.g. Taswell (1981), Cyr et al. (1993), Chick (1996)) and some of
those results are applicable here.
Maximum likelihood methods may be used to estimate the unknown parameters in the
function f(n). The log-likelihood for the data is
f =
M3
i=1
xi log(h(µi)) + (ki − xi) log(1− h(µi)) (5)
where ki and xi are, respectively, the total number of tests and the number of positive
responses at dilution level i. Numerical maximization of (5) is required to obtain the mle’s θˆ
and φˆ. Variances of these estimates may be obtained by inverting the negative of the matrix
of second derivatives of f (see appendix). Cyr et al. (1993) discusses the relative merits of
diﬀerent approaches for generating confidence intervals for θ. If all of the negative control
samples test negative, then φˆ ≈ 1 and confidence intervals for φ based on asymptotic results
will not be valid. However, by applying the ”rule of three’s” (Handley and Lippman-Hand,
1983) a 95% confidence interval for φ is given by [(k0− 3)/k0, 1.0] where k0 is the number of
negative control samples. This confidence interval is conservative in the sense that it does
not use any of the information from the dilutions where µi > 0 for estimating φ.
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For a given n, the estimated sensitivity (1 - specificity if n = 0) is
αˆ = 1− φˆ(1− θˆ)n (6)
while the value of n that corresponds to a sensitivity of α may be estimated by
nˆ =
log(1− α)− log(φˆ)
log(1− θˆ)
(7)
The asymptotic variances of these estimates are given in the appendix.
2.2 Nonparametric estimation of f
There is no assurance that the parametric model described above will provide a good fit
to the curve f(n). As an alternative, isotonic regression methods (Barlow et al., 1972)
can be used to provide a nonparametric estimate of an arbitrary non-decreasing function.
Typically, however, isotonic regression is used to regress an observed response against an
observed covariate. For example, if data were available at each n, then a simple isotonic
regression estimate of f could be obtained using the “pool adjacent violators” algorithm.
Specifically, let f(n) be the unconstrained estimate of the detection probability when exactly
n molecules of DNA are in the sample. That is,
f(n) = xn/kn (8)
Then the isotonic regression estimate of f on n is defined by
f I(n) = min
t≥n
max
s≤n
t3
i=s
knf(i)/
t3
i=s
kn (9)
Heuristically, this formula sets f I equal to f for portions of the curve where f is non-
decreasing and sets f I equal to the average of the f where f is decreasing. It can be shown
that this algorithm gives the constrained mle of f .
Unfortunately, as we have noted, it is not possible to directly observe xn and kn for
specific n. However, it is possible to define an iterative estimation scheme using an EM
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algorithm (Dempster et al, 1978) that combines the usual E-step with an isotonic regression
in the M-step. At iteration j the EM algorithm simply replaces equation 8 with
f (j)(n) =
M
i=1 xiPr(n | x = 1, µi, f I(j−1))M
i=1 xiPr(n | x = 1, µi, f I(j−1)) + (ki − xi)Pr(n | x = 0, µi, f I(j−1))
(10)
where f I(j−1) is the current estimate of f I and
Pr(n | x, µ, f) = f(n)
x(1− f(n))1−xµn/n!

ν f(ν)x(1− f(ν))1−xµν/ν!
(11)
is the conditional probability that the number of molecules in the aliquot is n, given the
observed data and current estimate of f I . The f (j) are then adjusted using the isotonic
regression equation (9) to produce a new value of f I(j). The quantity kn in equation 9,
which acts as a weight in the isotonic regression, is replaced by the denominator of equation
10. A convenient starting estimate of f is given by
f 0(n) =
M
i=1 xiPr(n | µi)M
i=1 Pr(n | µi)
(12)
where Pr(n|µi) is the Poisson probability given in (1). Estimation of α for a given n and
inverse estimation of n for a given α may be accomplished in a straightforward manner from
a plot or table of f I(n) versus n. The asymptotic properties of this model (in particular
standard errors) are unclear, however, since the number of parameters is unlimited.
2.3 Semiparametric estimation of f
As a compromise between the strong assumptions of a parametric model for f and the
typically rough nonparametric estimate of f , we consider modeling f as an arbitrary smooth,
but monotonic, function of n. While splines are often used to model smooth functions
(e.g. Wahba, 1990), modeling a monotone function using standard spline methods would be
diﬃcult since the model parameters would need to be constrained to ensure monotonicity.
Ramsay (1998), however, developed a simple transformation that guarantees monotonicity
8
Hosted by The Berkeley Electronic Press
of a spline function without constraints on the parameters. Following Ramsay (1998) we
define f as
logitf(n) = β0 + β1(
8
exp(
8
w(n))) (13)
where w(n) is an arbitrary smooth (spline-based) function (see below for further details).
Since the form of w is arbitrary the coeﬃcients in the model for w are unconstrained.
Nonetheless, f will be monotonic in n (increasing if β1 > 0 and decreasing if β1 < 0).
In addition, by modeling the logit of f , we also remove any constraints on the β’s due to
bounds on f .
To fit this function we maximize the penalized log likelihood
f =
M3
i=1
xi log(h(µi)) + (ki − xi) log(1− h(µi))− ρ
8 ∞
0
w2(n)dn (14)
where ρ controls the smoothness of the fit. For ρ = 0, f equals the nonparametric regression
estimate given in the previous section (assuming suﬃcient knots are used in defining w - see
below) while ρ =∞ leads to a straight line on the logit scale.
The function w(n) may be defined as a linear combination of an arbitrary set of basis
functions,
w(n) =
3
i
ciφi(n).
The M-spline basis described in Ramsay (1988) forms a convenient set of basis functions, φ,
since the integral
$
w(n) is then a simple function of the I-spline basis functions, Φ:
8
w(n) =
3
i
ciΦi(n).
In deriving the bases, we choose knot positions based on the regions of maximum curvature
seen in a plot of the nonparametric estimate of f . A large number of knots are typically
included and the smoothing parameter ρ is used to reduce the eﬀective degrees of freedom
and avoid overfitting.
A simple cross-validation algorithm may be used to determine the value of ρ. At each
dilution level, a single positive result is removed from the data, the model is refit and the
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misclassification error for the excluded result is computed (i.e. since the excluded result is a
positive test, the misclassification error is the probability of a negative test at that dilution
level based on equation 2). This procedure is repeated for a negative result at each dilution
level. The total misclassification error at a given dilution level is the number of positive
results at that dilution level times the misclassification probability for a positive result plus
the number of negative results at that dilution level times the misclassification probability
for a negative result. The misclassification errors are then summed over the dilution levels.
The value of ρ that minimizes the total misclassification error is used in the final model.
Estimation of α for a given n and inverse estimation of n for a given αmay be obtained in a
straightforward manner from the fitted spline model. Confidence intervals for these estimates
may be obtained using the approximate bootstrap confidence interval (ABC) described by
Efron and Tibshirani (1993; pg 328). The ABC method has good asymptotic properties
and requires fewer model fits than standard bootstrap confidence intervals that rely on
resampling.
3 Example
An experiment was designed to estimate the sensitivity and specificity of a new PCR-based
test for detecting M. genitalium. PCR amplifications were run on 100 µl aliquots of M. geni-
talium at eight dilution levels (mean concentrations of 64, 32, 16, 8, 4, 2, 1 and 0 molecules of
DNA per 100 µl). Each aliquot was classified as positive or negative by a microwell detection
assay (see Dutro et al., 2002 for further details). The data are summarized in table 1.
¡table 1 here¿
Figure 1 shows the three fitted models for f(n) while table 2 provides estimates of key
quantities based on these models. All three curves suggest that the probability of a positive
test is substantially less than 1.0 when only a few copies of the target DNA are available.
Also, there is no clear detection limit above which tests will always be positive and below
10
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which tests will always be negative. The parametric and semiparametric models agree quite
well at low copy numbers but then the semiparametric curve rises more quickly and flattens
out sooner than the parametric curve, leading to substantial diﬀerences in estimates of the
minimum detectable copy number for sensitivities above 90%. The nonparametric model
is broadly similar to the parametric and semiparametric models but the roughness of the
nonparametric curve makes detailed comparisons more diﬃcult.
¡figure 1 here¿
¡table 2 here¿
Figure 2 shows the observed data and the observed sensitivity curves the parametric and
semiparametric models. Both agree well with the observed data.
¡figure 2 here¿
4 Discussion
The term sensitivity has been used in a number of ways in the literature on PCR-based
tests. However, none of the definitions acknowledge that sensitivity may depend on the
number of target cells or molecules in the sample. While this assumption may be reasonable
for less sensitive tests that have detection limits in the hundreds or thousands of targets, it
seems less reasonable for highly sensitive PCR-based tests. In any event it is an assumption
that can be checked with appropriate data. We argue that the sensitivity of a test should
be characterized by a curve showing the probability of a positive test as a function of the
number of target DNA molecules in the sample. Note that we distinguish the test sensitivity
and specificity as defined herein from clinical sensitivity and specificity. The latter would also
depend on patient characteristics, the presence of non- target bacteria that might cross-react
with the PCR primers, eﬃciency of lysis of bacteria to free the DNA, specimen preparation
and other aspects of the clinical sample collection procedure.
An endpoint dilution experiment may be used to estimate the sensitivity and specificity
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of a PCR-based test. An important limitation of the endpoint dilution design, however, is
that the test sensitivity is confounded with variability in DNA concentration. Nonetheless,
by assuming that the number of DNA copies in a particular sample follows a Poisson dis-
tribution it is possible to estimate the sensitivity curve, f(n), from the observed counts of
positive and negative results at various dilution levels. We describe parametric, nonpara-
metric and semiparametric models for f(n). In each case the resulting curve is constrained
to be monotonically increasing.
Generally, use of the parametric model (3) will be computationally fastest and easiest to
implement. This model is also easy to interpret in the sense that sensitivity and specificity
are each characterized by a single parameter. However, this model assumes a particular
functional form for f(n) and data at one dilution level can strongly influence the curve at
other, distant dilution levels. In contrast, the eﬀect of the data is much more local in the
nonparametric model. However, in our application the nonparametric model gave a relatively
“rough” estimate of f(n) and this may generally be the case with the amount of laboratory
data typically available. As a compromise between these two approaches, a model based on
monotonic smoothing splines can provide a smooth curve for f(n) with minimal assumptions
and reduced influence of the data on distant dilution levels. However, the spline-based model
is more computationally intensive than the parametric model, especially for computing con-
fidence intervals. Also, comparisons between sensitivity curves from two or more competing
tests may be more diﬃcult with the spline-based model. For the data analyzed here, the
spline-based model suggested that the parametric model provided a reasonable fit. There is
no guarantee that this will be generally true, however.
Thus far, we have assumed that the expected number of DNA targets, µ, is known
exactly. In practice, however, there is some uncertainty about the initial concentration of
targets and addition uncertainty may be introduced during the process of serial dilution. If
the investigator is willing/able to quantify this uncertainty, then it is possible to incorporate
it into the analysis. Suppose that the expected number of targets at dilution level i may be
12
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described by a gamma distribution with mean µi and squared coeﬃcient of variation equal
to 1/c. Then the conditional distribution of n given µi and c is negative binomial,
Pr(n | µi, c) = Γ(n+ c)Γ(n+ 1)Γ(c)
X
µi
µi + c
~n X
c
µi + c
~c
. (15)
This distribution may be incorporated into the parametric, nonparametric or semiparametric
analyses. If the parametric model (3) holds, the observed probability of a positive test has
the simple form
h(µi, c) = 1− φ
w
1 +
µi
c
θ
W−c
. (16)
This quantity may be used in the likelihood (5) to obtain estimates of φ and θ.
Once sensitivity and specificity have been estimated, the unknown concentration of target
DNA in a new sample may be estimated using an LDA experiment. Let λ be the unknown
concentration in the new sample and let di be the dilution factor for the i’th dilution level (so
the concentration at the i’th dilution level is λ/di). Then an estimate of λ may be obtained
by solving the following equation for λ,
3
i
xi
dh
p
λ
di
Q
dλ
h
p
λ
di
Q =
3
i
(ki − xi)
dh
p
λ
di
Q
dλ
1− h
p
λ
di
Q (17)
If the parametric model (3) is used for f(n) then the estimate of λ is the solution to
3
i
φˆxi
di
p
exp(θˆλ/di)− φˆ
Q =
3
i
ki − xi
di
. (18)
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Appendix
The expected information about φˆ and θˆ from model (3) is



i
µ2i kiφ exp(−θµi)
1−φ exp(−θµi) −

i
µiki exp(−θµi)
1−φ exp(−θµi)
−i µiki exp(−θµi)1−φ exp(−θµi)

i
ki exp(−2θµi)
1−φ exp(−θµi)

 (19)
Asymptotic variances are obtained by inverting this matrix. In some applications, it may be
reasonable to treat φ as fixed at 1.0. In that case,
Var(θˆ) =
3
i
µ2i ki exp(−θµi)
1− exp(−θµi)
(20)
The delta method may then be used to derive the asymptotic variances of αˆ and nˆ in
equations 6 and 7, respectively,
Var(αˆ) = (1− θˆ)2nVar(φˆ) + 2nφˆ(1− θˆ)2n−1Cov(φˆ, θˆ) + n2φ2(1− θˆ)2n−2Var(θˆ) (21)
Var(nˆ) =
Var(φˆ)
φˆ2 log2(1− θˆ)
−
2Cov(φˆ, θˆ) log 1−α
φˆ
φˆ(1− θˆ) log3(1− θˆ)
+
Var(θˆ) log2 1−α
φˆ
(1− θˆ)2 log4(1− θˆ)
(22)
16
Hosted by The Berkeley Electronic Press
Table 1: Data from an endpoint dilution experiment on M. genitalium
Mean number of Number of Number Number
molecules per 100 ul replicates positive negative
64 16 16 0
32 16 15 1
16 16 14 2
8 16 15 1
4 16 11 5
2 16 6 10
1 16 5 11
0 22 0 22
17
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Table 2: Estimates of specificity, sensitivity for a given number of DNA copies and detectable
number of DNA copies for a given sensitivity (α) for the data in table1.
sensitivity Minimum detectable number
Model specificity n = 1 n = 10 n = 20 α = .50 α = .95
parametric 1.0 0.20 0.89 0.99 3.1 13.4
nonparametric 1.0 0.41 0.91 0.91 3.2 36.6
semiparametric 0.98 0.18 0.90 0.93 2.0 28.6
95% CI for (0.96 - (0.05 - (0.79 - (0.82 - (1.3 - (6.2 -
semiparametric 0.99) 0.42) 0.97) 0.99) 2.9) 50.6)
estimates based
on ABC method
18
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